Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

GRTX Stock Annual Income Statement. Download in Excel

Galera Therapeutics Inc. logo

Galera Therapeutics Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

0.03
 
USD
  
0.00
  
(1.19%)
Previous close: 0.0336  Open: 0.0338  Bid:   Ask:
52 week range    
0.03   
   0.29
Mkt Cap: 2 M  Avg Vol (90 Days): 147,525
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Thursday 5th December 2024

Stock Rankings

30
MarketXLS Rank
60
Value
7
Technical
23
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

GRTX Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22Dec-23
AccretionOnPreferredStock7 M
Basic EPS from continuing operations-2.98-3.12-2.3-1.33
Basic EPS total-2.98-3.12-2.3-1.33
Basic weighted shares outstanding4 M25 M26 M27 M45 M
Depreciation-300000.0400000.0800000.0114000.0259000.0
DepreciationAndAmortization-300000.0400000.0800000.0114000.0259000.0
Diluted EPS total-16.31-2.98-3.12-2.3-1.33
Diluted normalized net income/share-2.3-1.33
Diluted weighted shares outstanding3 M25 M26 M27 M45 M
GeneralAndAdministrativeExpense8 M16 M21 M20 M23 M
Income before tax-52 M-74 M-81 M-62 M-59 M
Income restructuring and M&A2 M
Income taxes-9000.0-16000.0-70000.0
Interest income2 M1 M32000.0506000.02 M
InterestExpenseNonOperating3 M5 M7 M12 M11 M
Net income from total operations-52 M-74 M-81 M-62 M-59 M
NetIncomeCommonStockholders-59 M-74 M-81 M-62 M-59 M
NetIncomeContinuousOperations-52 M-74 M-81 M-62 M-59 M
NetNonOperatingInterestIncomeExpense-1 M-4 M-7 M-11 M-10 M
Normalized income-56 M-33 M
Operating income-51 M-71 M-73 M-51 M-49 M
Operating income before depreciation (EBITDA)-49 M-69 M-73 M-51 M-47 M
OperatingExpense51 M71 M73 M51 M47 M
Other special charges-3 M5 M7 M12 M11 M
OtherGandA8 M16 M21 M20 M23 M
OtherOperatingExpenses-315000.0297000.0325000.0267000.0191000.0
OtherunderPreferredStockDividend7 M
PreferredStockDividends7 M
RentAndLandingFees8 M
Research & development expense42 M55 M52 M31 M24 M
ResearchExpense42 M55 M52 M31 M24 M
RestructringAndMnAIncome2 M
SalariesAndWages-2 M
Selling Gen & administrative expense8 M16 M21 M20 M23 M
Special income/charges3 M-5 M-7 M-12 M-2 M
Total Income available for interest expense (EBIT)-49 M-69 M-73 M-51 M-48 M
Total common shares outstanding25 M25 M27 M43 M54 M
Total net income-52 M-74 M-81 M-62 M-59 M
Total ordinary shares54 M54 M54 M54 M54 M
TotalExpenses51 M71 M73 M51 M47 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University